×
Min. Age:
Max. Age:
Gender:
Reason:
Duration:

Beconase AQ

Generic Name: Beclomethasone
Drug Category: Corticosteroid
Litigation Alert Level: Low
This drug has been approved for use by males and females over the age of 6 years old for a maximum duration of 3 weeks.

Approved Uses

Indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis and for the prevention of recurrence of nasal polyps following surgical removal.

BECONASE AQ Nasal Spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement.

If recommended doses of intranasal beclomethasone are exceeded or if individuals are particularly sensitive or predisposed by virtue of recent systemic steroid therapy, symptoms of hypercorticism may occur, including very rare cases of menstrual irregularities, acneiform lesions, cataracts, and cushingoid features.

Intranasal corticosteroids should be used with caution, if at all, in patients with active or quiescent tuberculous infections of the respiratory tract, untreated local or systemic fungal or bacterial infections, systemic viral or parasitic infections, or ocular herpes simplex.

Because of the inhibitory effect of corticosteroids on wound healing, patients who have experienced recent nasal septal ulcers, nasal surgery, or nasal trauma should not use a nasal corticosteroid until healing has occurred.

Intranasal corticosteroids may cause a reduction in growth velocity when administered to pediatric patients.

During withdrawal from oral corticosteroids, some patients may experience symptoms of withdrawal, e.g., joint and/or muscular pain, lassitude, and depression.

Rare instances of nasal septum perforation have been spontaneously reported.

Rare instances of wheezing, cataracts, glaucoma, and increased intraocular pressure have been reported following the intranasal use of beclomethasone dipropionate.

There are no adequate and well-controlled studies in pregnant women. Animal studies: teratogenic and embryocidal.

Hypoadrenalism may occur in infants born of mothers receiving corticosteroids during pregnancy. Such infants should be carefully observed.

It is not known whether beclomethasone dipropionate is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be exercised when BECONASE AQ Nasal Spray is administered to a nursing woman.

GoToSource

Off-label Uses

• Sinus infections and treatment of nasal polyps (rather than preventing them from returning after surgery). GoToSource

• Graft-versus-host disease of the gastrointestinal tract. GoToSource

• Use in patients under the age of 6 years. GoToSource 

• Crohn’s disease and ulcerative colitis. GoToSource

• Stoma inflammation. GoToSource

• Chronic obstructive pulmonary disease. GoToSource

• Pyoderma gangrenosum. GoToSource

• Reduce bronchopulmonary dysplasia in preterm infants. GoToSource 

• Non-specific chronic cough. GoToSource

Adverse Events

Glucocorticoid-induced osteoporosis. GoToSource

Fractures with increased doses. GoToSource

Risk of cataracts. GoToSource

Hypertrichosis in children (abnormal hair growth). GoToSource

Growth impairment and adrenal suppression with long-term use. GoToSource

Septum perforation. GoToSource

Candidiasis (fungal infection). GoToSource

Litigation

No major injury lawsuits reported.

The material contained in GoToPills is for informational purposes only and not intended to replace the judgment, evaluation and treatment of physicians, pharmacists and other healthcare providers. GoToPills does not provide medical advice, diagnoses or treatment. Always seek the advice of your physician or other qualified health provider regarding a medical condition or treatment.

 

 iOSAndroidAppOrchard - EPIC EHR

Site Last Updated March 29, 2024